Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new revision tag indicates the system was updated from v3.6.4 to v3.6.5. This reflects an incremental platform update rather than changes to page content.
    Difference
    0.1%
    Check dated 2026-08-08T17:11:58.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page content remained unchanged. There are no additions or deletions to report.
    Difference
    0.1%
    Check dated 2026-08-01T14:12:32.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s revision label advanced from v3.6.3 to v3.6.4, indicating an internal deployment or version update. This update does not reflect changes to the study content displayed on the page.
    Difference
    0.1%
    Check dated 2026-07-25T09:31:09.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The Study Details page revision tag updates from v3.6.2 to v3.6.3, indicating a small platform update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T21:59:32.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page footer's revision tag was updated from v3.6.0 to v3.6.2, indicating a backend or template update; the visible study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-26T23:56:12.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    New metadata and navigation elements were added: Weijia Fang, MD appears as the contact line, verification-related labels were introduced, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. Formatting was standardized from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated to v3.6.0.
    Difference
    2%
    Check dated 2026-06-12T16:31:41.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.